1Bergstrom J, Lindholm B, Lacson E Jr,et al.What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?Semin Dial,2000,13:163-175.
2Arici M, Walls J.End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link?Kidney Int,2001,59:407-414.
3Hou FF, Miyata T, Boyce J,et al.beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.Kidney Int,2001,59:990-1002.
4Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease.Am J Kidney Dis,1998,32(5 Suppl 3):S112-S119.
5Kaysen GA. C-reactive protein: a story half told.Semin Dial,2000,13:143-146.
6Craven TE, Ryu JE, Espeland MA, et al.Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.Circulation,1990,82:1230-1242.
7Moustapha A, Naso A, Nahlawi M,et al.Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.Circulation,1998,97:138-141.
8Massy ZA, Ceballos I, Chadefaux-Vekemens B, et al. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. Kidney Int,2001,59 (Suppl 78): S243-S245.
